Form 10-Q Doximity, Inc. For: Jun 30

Go back to Form 10-Q Doximity, Inc. For: Jun 30

Doximity Inc (DOCS) PT Raised to $31 at Piper Sandler

August 12, 2024 10:05 AM EDT

Piper Sandler analyst Sean Wieland raised the price target on Doximity Inc (NYSE: DOCS) to $31.00 (from $28.00) while maintaining a Neutral rating.

The analyst comments "DOCS delivered a big beat and raise on 8/8/24, with F1Q revenues of $126.7M exceeding the high end of... More

Needham Upgrades Doximity Inc (DOCS) to Buy

August 9, 2024 7:10 AM EDT

Needham analyst Scott Berg upgraded Doximity Inc (NYSE: DOCS) from Hold to Buy with a price target of $38.00.

The analyst comments "We are upgrading DOCS from Hold to Buy as momentum with large customers, particularly pharma, helped drive Q1 upside and an FY25... More

Doximity Inc (DOCS) PT Raised to $34 at Evercore ISI

August 9, 2024 5:04 AM EDT

Evercore ISI analyst Elizabeth Anderson raised the price target on Doximity Inc (NYSE: DOCS) to $34.00 (from $29.00) while maintaining a In Line rating.

The analyst comments "DOCSs strong print this evening wraps up a relatively solid performance from HCIT this week(!). And despite... More